(Q47399212)

English

Nanogel-based scaffold delivery of prostaglandin E(2) receptor-specific agonist in combination with a low dose of growth factor heals critical-size bone defects in mice

scientific article published in April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Nanogel-based scaffold delivery of prostaglandin E(2) receptor-specific agonist in combination with a low dose of growth factor heals critical-size bone defects in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

prostaglandin E2

1 reference

based on heuristic

inferred from title

Kazunari Akiyoshi

13

object named as

Kazunari Akiyoshi

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

author name string

Paksinee Kamolratanakul

1

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Tadayoshi Hayata

2

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Yoichi Ezura

3

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Aya Kawamata

4

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Chikako Hayashi

5

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Yuka Yamamoto

6

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Hiroaki Hemmi

7

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Masashi Nagao

8

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Ryo Hanyu

9

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Takuya Notomi

10

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Tetsuya Nakamoto

11

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Teruo Amagasa

12

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Masaki Noda

14

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

63

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

4

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

1021-1033

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

Purification and characterization of other distinct bone-inducing factors

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Recombinant human bone morphogenetic protein induces bone formation

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Prostaglandins: mechanisms of action and regulation of production in bone

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Prostaglandin E receptor subtypes in mouse osteoblastic cell line

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Prostaglandin E(2) receptors in bone formation

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Self-assembled cationic nanogels for intracellular protein delivery

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Bone tissue engineering by gene delivery

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

TAK1 is an essential regulator of BMP signalling in cartilage

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Phylogenetic footprinting and genome scanning identify vertebrate BMP response elements and new target genes.

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Osteoclast differentiation in ectopic bone formation induced by recombinant human bone morphogenetic protein 2 (rhBMP-2)

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Controversial effects of non-steroidal anti-inflammatory drugs on bone: a review

1 reference

https://api.crossref.org/works/10.1002%2FART.30151

21 January 2018

Identifiers

10.1002/ART.30151

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 January 2018

http://europepmc.org/abstract/MED/21190246

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47399212&oldid=2155175714"